Cargando…
Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience
BACKGROUND: Epidemiological studies commonly identify the clinical characteristics and survival outcomes of patients with breast cancer at five years. Our study aims to describe the sociodemographic, clinicopathological characteristics and determine the long-term event-free survival (EFS) and overal...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444821/ https://www.ncbi.nlm.nih.gov/pubmed/32833983 http://dx.doi.org/10.1371/journal.pone.0237811 |
_version_ | 1783573872330670080 |
---|---|
author | De-la-Cruz-Ku, Gabriel Luyo, Marianne Morante, Zaida Enriquez, Daniel Möller, Mecker G. Chambergo-Michilot, Diego Flores, Lucero Luque, Renato Saavedra, Antonella Eyzaguirre-Sandoval, Miguel E. Luján-Peche, María G. Noel, Naysha Calderon, Hafid Razuri, Cesar Fuentes, Hugo A. Cotrina, Jose Manuel Neciosup, Silvia P. Araujo, Jhajaira Lema, Alexandra Pinto, Joseph Gomez, Henry L. Valcarcel, Bryan |
author_facet | De-la-Cruz-Ku, Gabriel Luyo, Marianne Morante, Zaida Enriquez, Daniel Möller, Mecker G. Chambergo-Michilot, Diego Flores, Lucero Luque, Renato Saavedra, Antonella Eyzaguirre-Sandoval, Miguel E. Luján-Peche, María G. Noel, Naysha Calderon, Hafid Razuri, Cesar Fuentes, Hugo A. Cotrina, Jose Manuel Neciosup, Silvia P. Araujo, Jhajaira Lema, Alexandra Pinto, Joseph Gomez, Henry L. Valcarcel, Bryan |
author_sort | De-la-Cruz-Ku, Gabriel |
collection | PubMed |
description | BACKGROUND: Epidemiological studies commonly identify the clinical characteristics and survival outcomes of patients with breast cancer at five years. Our study aims to describe the sociodemographic, clinicopathological characteristics and determine the long-term event-free survival (EFS) and overall survival (OS) of a Peruvian population with triple-negative breast cancer. METHODS: We reviewed the medical records of new cases treated at a single institution in the period 2000–2014. The survival analysis included patients with stages I-IV. Survival estimates at 10 years were calculated with the Kaplan-Meier method and compared with the Log-rank test. We further used multivariate Cox regression analysis to calculate prognostic factors of recurrence and mortality. RESULTS: Among the 2007 patients included, the median age at diagnosis was 49 years (19–95 years). Most patients presented histologic grade III (68.7%), tumor stage II (34.2%), and III (51.0%) at diagnosis. Local and distant relapse was present in 31.9 and 51.4% of the patients, respectively. The most frequent sites of metastasis were the lungs (14.5%), followed by bone (9.7%), brain (9.6%), and liver (7.9%). The median follow-up was 153 months. At 3, 5, and 10 years, the EFS of the population was 55%, 49%, and 41%, respectively, while the OS was 64%, 56%, and 47%, respectively. Moreover, an N3 lymph node status was the most important prognostic factor for both disease relapse (HR: 2.54, 95% CI: 2.05–3.15) and mortality (HR: 2.51, 95% CI: 2.01–3.14) at ten years. An older age and higher T staging were associated with a worse OS, while patients who received radiotherapy and adjuvant chemotherapy had better survival rates. CONCLUSION: The sociodemographic features of Peruvian patients with TNBC are similar to those of other populations. However, our population was diagnosed at more advanced clinical stages, and thus, EFS and OS were lower than international reports while prognostic factors were similar to previous studies. |
format | Online Article Text |
id | pubmed-7444821 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-74448212020-08-27 Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience De-la-Cruz-Ku, Gabriel Luyo, Marianne Morante, Zaida Enriquez, Daniel Möller, Mecker G. Chambergo-Michilot, Diego Flores, Lucero Luque, Renato Saavedra, Antonella Eyzaguirre-Sandoval, Miguel E. Luján-Peche, María G. Noel, Naysha Calderon, Hafid Razuri, Cesar Fuentes, Hugo A. Cotrina, Jose Manuel Neciosup, Silvia P. Araujo, Jhajaira Lema, Alexandra Pinto, Joseph Gomez, Henry L. Valcarcel, Bryan PLoS One Research Article BACKGROUND: Epidemiological studies commonly identify the clinical characteristics and survival outcomes of patients with breast cancer at five years. Our study aims to describe the sociodemographic, clinicopathological characteristics and determine the long-term event-free survival (EFS) and overall survival (OS) of a Peruvian population with triple-negative breast cancer. METHODS: We reviewed the medical records of new cases treated at a single institution in the period 2000–2014. The survival analysis included patients with stages I-IV. Survival estimates at 10 years were calculated with the Kaplan-Meier method and compared with the Log-rank test. We further used multivariate Cox regression analysis to calculate prognostic factors of recurrence and mortality. RESULTS: Among the 2007 patients included, the median age at diagnosis was 49 years (19–95 years). Most patients presented histologic grade III (68.7%), tumor stage II (34.2%), and III (51.0%) at diagnosis. Local and distant relapse was present in 31.9 and 51.4% of the patients, respectively. The most frequent sites of metastasis were the lungs (14.5%), followed by bone (9.7%), brain (9.6%), and liver (7.9%). The median follow-up was 153 months. At 3, 5, and 10 years, the EFS of the population was 55%, 49%, and 41%, respectively, while the OS was 64%, 56%, and 47%, respectively. Moreover, an N3 lymph node status was the most important prognostic factor for both disease relapse (HR: 2.54, 95% CI: 2.05–3.15) and mortality (HR: 2.51, 95% CI: 2.01–3.14) at ten years. An older age and higher T staging were associated with a worse OS, while patients who received radiotherapy and adjuvant chemotherapy had better survival rates. CONCLUSION: The sociodemographic features of Peruvian patients with TNBC are similar to those of other populations. However, our population was diagnosed at more advanced clinical stages, and thus, EFS and OS were lower than international reports while prognostic factors were similar to previous studies. Public Library of Science 2020-08-24 /pmc/articles/PMC7444821/ /pubmed/32833983 http://dx.doi.org/10.1371/journal.pone.0237811 Text en © 2020 De-la-Cruz-Ku et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article De-la-Cruz-Ku, Gabriel Luyo, Marianne Morante, Zaida Enriquez, Daniel Möller, Mecker G. Chambergo-Michilot, Diego Flores, Lucero Luque, Renato Saavedra, Antonella Eyzaguirre-Sandoval, Miguel E. Luján-Peche, María G. Noel, Naysha Calderon, Hafid Razuri, Cesar Fuentes, Hugo A. Cotrina, Jose Manuel Neciosup, Silvia P. Araujo, Jhajaira Lema, Alexandra Pinto, Joseph Gomez, Henry L. Valcarcel, Bryan Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience |
title | Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience |
title_full | Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience |
title_fullStr | Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience |
title_full_unstemmed | Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience |
title_short | Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience |
title_sort | triple-negative breast cancer in peru: 2000 patients and 15 years of experience |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444821/ https://www.ncbi.nlm.nih.gov/pubmed/32833983 http://dx.doi.org/10.1371/journal.pone.0237811 |
work_keys_str_mv | AT delacruzkugabriel triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT luyomarianne triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT morantezaida triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT enriquezdaniel triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT mollermeckerg triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT chambergomichilotdiego triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT floreslucero triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT luquerenato triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT saavedraantonella triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT eyzaguirresandovalmiguele triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT lujanpechemariag triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT noelnaysha triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT calderonhafid triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT razuricesar triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT fuenteshugoa triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT cotrinajosemanuel triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT neciosupsilviap triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT araujojhajaira triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT lemaalexandra triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT pintojoseph triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT gomezhenryl triplenegativebreastcancerinperu2000patientsand15yearsofexperience AT valcarcelbryan triplenegativebreastcancerinperu2000patientsand15yearsofexperience |